Biogen Eisai's Leqembi Alzheimer's drug rejected by EU regulator
European drug regulators on Friday rejected Leqembi's Alzheimer's treatment Biogen and Eisaicreating another hurdle for companies as they struggle to…
Biotechnology and pharmaceuticals
Bristol Myers Squibb (BMY) Q2 2024 Results
Bristol Myers Squibb's research and development center at Cambridge Crossing in Cambridge, Massachusetts, on December 27, 2023. Adam Glanzman |…
Fund manager of names in weight loss and biotechnology
Weight-loss drugs have sparked investor interest and shaken up other sectors over the past year. Novo Nordisk and Eli Lilly…
Viking Therapeutics shares rise on plans to test weight-loss injection
Weight loss drug concept. Cr | Istock | Getty Images Actions of Viking Therapeutics rose more than 20% on Thursday…
Pfizer's gene therapy for hemophilia A successfully passes late-stage trials
Kena Betancur | Corbis News | Getty Images Pfizer On Wednesday, the US drugmaker announced that its experimental gene therapy…
First round of Medicare drug price negotiations nearing end
Activists protest prescription drug prices in front of the U.S. Department of Health and Human Services building in Washington, DC,…
Novo Nordisk's Wegovy gets UK approval for use in reducing heart risks
Novo Nordisk's Wegovy weight loss drug has experienced a meteoric rise in popularity. Nurphoto | Getty Images LONDON — The…
Lawmakers unveil PBM reform bill amid rising drug costs
Fever on the surface | Getty Images Bipartisan lawmakers on Tuesday introduced a new bill that aims to crack down…
Ozempic may reduce dementia risk and nicotine use
A box of Ozempic manufactured by Novo Nordisk is seen at a pharmacy in London, Britain, March 8, 2024. Hollie…
Drug makers race to develop weight loss pills
The man who made Aykut Stock Images | Getty Images Do you think a friend or colleague should receive this…